RESUMEN
The neuropeptide vasopressin is known for its regulation of osmotic balance in mammals. Arginine vasotocin (AVT) is a non-mammalian homolog of this neuropeptide that is present in fish. Limited information suggested that vasopressin and its homologs may also influence reproductive function. In the present study, we investigated the direct effect of AVT on spermatogenesis, using zebrafish as a model organism. Results demonstrate that AVT and its receptors (avpr1aa, avpr2aa, avpr1ab, avpr2ab, and avpr2l) are expressed in the zebrafish brain and testes. The direct action of AVT on spermatogenesis was investigated using an ex vivo culture of mature zebrafish testes for 7 days. Using histological, morphometric, and biochemical approaches, we observed direct actions of AVT on zebrafish testicular function. AVT treatment directly increased the number of spermatozoa in an androgen-dependent manner, while reducing mitotic cells and the proliferation activity of type B spermatogonia. The observed stimulatory action of AVT on spermiogenesis was blocked by flutamide, an androgen receptor antagonist. The present results support the novel hypothesis that AVT stimulates short-term androgen-dependent spermiogenesis. However, its prolonged presence may lead to diminished spermatogenesis by reducing the proliferation of spermatogonia B, resulting in a diminished turnover of spermatogonia, spermatids, and spermatozoa. The overall findings offer an insight into the physiological significance of vasopressin and its homologs in vertebrates as a contributing factor in the multifactorial regulation of male reproduction.
Asunto(s)
Receptores de Vasopresinas , Espermatogénesis , Testículo , Vasotocina , Pez Cebra , Animales , Pez Cebra/metabolismo , Masculino , Vasotocina/metabolismo , Vasotocina/farmacología , Testículo/metabolismo , Receptores de Vasopresinas/metabolismo , Receptores de Vasopresinas/genética , Proteínas de Pez Cebra/metabolismo , Proteínas de Pez Cebra/genética , Espermatozoides/metabolismo , Proliferación Celular , Espermatogonias/metabolismo , Espermatogonias/citologíaRESUMEN
Autism spectrum disorder (ASD) is a pervasive developmental disorder with gender differences. Oxytocin (OXT) is currently an important candidate drug for autism, but the lack of data on female autism is a big issue. It has been reported that the effect of OXT is likely to be different between male and female ASD patients. In the study, we specifically explored the role of the OXT signaling pathway in a VPA-induced female rat's model of autism. The data showed that there was an increase of either oxytocin or its receptor expressions in both the hippocampus and the prefrontal cortex of VPA-induced female offspring. To determine if the excess of OXT signaling contributed to autism symptoms in female rats, exogenous oxytocin and oxytocin receptor antagonists Atosiban were used in the experiment. It was found that exogenous oxytocin triggered autism-like behaviors in wild-type female rats by intranasal administration. More interestingly, several autism-like deficits including social interaction, anxiety, and repeat stereotypical sexual behavior in the VPA female offspring were significantly attenuated by oxytocin receptor antagonists Atosiban. Moreover, Atosiban also effectively improved the synaptic plasticity impairment induced by VPA in female offspring. Our results suggest that oxytocin receptor antagonists significantly improve autistic-like behaviors in a female rat model of valproic acid-induced autism.
Asunto(s)
Trastorno Autístico , Modelos Animales de Enfermedad , Oxitocina , Receptores de Oxitocina , Ácido Valproico , Vasotocina , Animales , Ácido Valproico/farmacología , Femenino , Receptores de Oxitocina/antagonistas & inhibidores , Receptores de Oxitocina/metabolismo , Oxitocina/farmacología , Oxitocina/metabolismo , Oxitocina/administración & dosificación , Ratas , Vasotocina/análogos & derivados , Vasotocina/farmacología , Trastorno Autístico/inducido químicamente , Trastorno Autístico/tratamiento farmacológico , Corteza Prefrontal/efectos de los fármacos , Corteza Prefrontal/metabolismo , Trastorno del Espectro Autista/inducido químicamente , Trastorno del Espectro Autista/tratamiento farmacológico , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Conducta Animal/efectos de los fármacos , Ratas Sprague-Dawley , Plasticidad Neuronal/efectos de los fármacos , Interacción Social/efectos de los fármacos , Conducta Sexual Animal/efectos de los fármacos , Ansiedad/tratamiento farmacológico , Ansiedad/inducido químicamente , EmbarazoRESUMEN
Arginine vasotocin (AVT) is produced mainly in the hypothalamus and as a neurohypophyseal hormone peripherally regulates water-mineral balance in sub-mammals. In addition, AVT-containing neurons innervate several areas of the brain, and AVT also acts centrally as both an anorexigenic and anxiogenic factor in goldfish. However, it is unclear whether these central effects operate in fish in general. In the present study, therefore, we investigated AVT-like immunoreactivity in the brain of the tiger puffer, a cultured fish with a high market value in Japan and also a representative marine teleost species, focusing particularly on whether AVT affects food intake and psychomotor activity. AVT-like immunoreactivity was distributed higher in the ventral region of the telencephalon, the hypothalamus and midbrain. Intraperitoneal (IP) administration of AVT at 100 pmol g-1 body weight (BW) increased the immunoreactivity of phosphorylated ribosomal proteinS6 (RPS6), a neuronal activation marker, in the telencephalon and diencephalon, decreased food consumption and enhanced thigmotaxis. AVT-induced anorexigenic and anxiogenic actions were blocked by IP co-injection of a V1a receptor (V1aR) antagonist, Manning compound (MC) at 300 pmol g-1 BW. These results suggest that AVT acts as an anorexigenic and anxiogenic factor via the V1aR-signaling pathway in the tiger puffer brain.
Asunto(s)
Receptores de Vasopresinas , Transducción de Señal , Vasotocina , Animales , Vasotocina/farmacología , Vasotocina/metabolismo , Receptores de Vasopresinas/metabolismo , Transducción de Señal/efectos de los fármacos , Takifugu/metabolismo , Inyecciones Intraperitoneales , Encéfalo/metabolismo , Encéfalo/efectos de los fármacos , Ingestión de Alimentos/efectos de los fármacos , Ansiedad/metabolismo , Ansiedad/inducido químicamente , Telencéfalo/metabolismo , Telencéfalo/efectos de los fármacosRESUMEN
BACKGROUND AND PURPOSE: With increasing life expectancy, benign prostatic hyperplasia (BPH) consequently affects more ageing men, illustrating the urgent need for advancements in BPH therapy. One emerging possibility may be the use of oxytocin antagonists to relax smooth muscle cells in the prostate, similar to the currently used (although often associated with side effects) α1-adrenoceptor blockers. EXPERIMENTAL APPROACH: For the first time we used live-imaging, combined with a novel image analysis method, to investigate the multidirectional contractions of the human prostate and determine their changes in response to oxytocin and the oxytocin antagonists atosiban and cligosiban. Human prostate samples were obtained and compared from patients undergoing prostatectomy due to prostate cancer as well as from patients with transurethral resection of prostate tissue due to severe BPH. KEY RESULTS: The two cohorts of tissue samples showed spontaneous multidirectional contractions, which significantly increased after the addition of oxytocin. Different to atosiban, which showed ambiguous effects of short duration, only long-acting cligosiban reliably prevented, as well as counteracted, any contractile oxytocin effect. Furthermore, cligosiban visibly reduced not only oxytocin-induced contractions, but also showed intrinsic activity to relax prostatic tissue. CONCLUSION AND IMPLICATIONS: Thus, the oxytocin antagonist cligosiban could be an interesting candidate in the search for novel BPH treatment options.
Asunto(s)
Contracción Muscular , Oxitocina , Próstata , Hiperplasia Prostática , Masculino , Humanos , Hiperplasia Prostática/tratamiento farmacológico , Próstata/efectos de los fármacos , Oxitocina/farmacología , Oxitocina/antagonistas & inhibidores , Contracción Muscular/efectos de los fármacos , Anciano , Persona de Mediana Edad , Vasotocina/análogos & derivados , Vasotocina/farmacologíaRESUMEN
Kisspeptin is an important hormone involved in the stimulation of the hypothalamo-pituitary gonadal (HPG) axis. The HPG axis can be suppressed in certain conditions such as stress, which gives rise to the activation of the hypothalamo-pituitary-adrenal (HPA) axis. However, the physiological role of kisspeptin in the interaction of HPG and HPA axis is not fully understood yet. This study was conducted to investigate the possible effects of central kisspeptin injection on HPG axis as well as HPA axis activity. Adult male Wistar rats were randomly divided into seven groups as followed: sham (control), kisspeptin (50 pmol), P234 (1 nmol), kisspeptin + p234, kisspeptin + antalarmin (0.1 µg), kisspeptin + astressin 2B (1 µg), and kisspeptin + atosiban (300 ng/rat) (n = 10 each group). At the end of the experiments, the hypothalamus, pituitary, and serum samples of the rats were collected. There was no significant difference in corticotropic-releasing hormone immunoreactivity in the paraventricular nucleus of the hypothalamus, serum adrenocorticotropic hormone, and corticosterone levels among all groups. Moreover, no significant difference was detected in pituitary oxytocin level. Serum follicle-stimulating hormone and luteinizing hormone levels of the kisspeptin, kisspeptin + antalarmin, and kisspeptin + astressin 2B groups were significantly higher than the control group. Serum testosterone levels were significantly higher in the kisspeptin kisspeptin + antalarmin, kisspeptin + astressin 2B, and kisspeptin + atosiban groups compared to the control group. Our findings suggest that central kisspeptin injection causes activation in the HPG axis, but not the HPA axis in male rats.
Asunto(s)
Sistema Hipotálamo-Hipofisario , Kisspeptinas , Sistema Hipófiso-Suprarrenal , Ratas Wistar , Animales , Masculino , Kisspeptinas/administración & dosificación , Kisspeptinas/farmacología , Kisspeptinas/metabolismo , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Sistema Hipotálamo-Hipofisario/metabolismo , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Sistema Hipófiso-Suprarrenal/metabolismo , Ratas , Fragmentos de Péptidos/administración & dosificación , Hormona Luteinizante/sangre , Hormona Luteinizante/metabolismo , Corticosterona/sangre , Vasotocina/farmacología , Vasotocina/administración & dosificación , Testosterona/sangre , Inyecciones Intraventriculares , Gónadas/metabolismo , Gónadas/efectos de los fármacos , Hipófisis/metabolismo , Hipófisis/efectos de los fármacos , Hormona Liberadora de Gonadotropina/metabolismo , Hormona Adrenocorticotrópica/sangre , Hormona Liberadora de Corticotropina , OligopéptidosRESUMEN
The medicinal plant Bryophyllum pinnatum was previously shown to block oxytocin (OT)-induced signals in myometrial cells, consistent with its tocolytic effect observed in patients. OT activates not only OT receptors but also V1A receptors, two receptors with high receptor homology that are both expressed in the myometrium and play a crucial role in myometrial contraction signaling. We aimed to study the molecular pharmacology of B. pinnatum herbal preparations using specific receptor ligands, the human myometrial cell line hTERT-C3, and cell lines expressing recombinant human OT and V1A receptors.We found that press juice from B. pinnatum (BPJ) inhibits both OT- and vasopressin (AVP)-induced intracellular calcium increases in hTERT-C3 myometrial cells. In additional assays performed with cells expressing recombinant receptors, BPJ also inhibited OT and V1A receptor-mediated signals with a similar potency (IC50 about 0.5 mg/mL). We further studied endogenous OT- and AVP-sensitive receptors in hTERT-C3 cells and found that OT and AVP stimulated those receptors with similar potency (EC50 of ~ 1 nM), suggesting expression of both receptor subtypes. This interpretation was corroborated by the antagonist potencies of atosiban and relcovaptan that we found. However, using qPCR, we almost exclusively found expression of OT receptors suggesting a pharmacological difference between recombinant OT receptors and native receptors expressed in hTERT-C3 cells.In conclusion, we show that B. pinnatum inhibits both OT and AVP signaling, which may point beyond its tocolytic effects to other indications involving a disbalance in the vasopressinergic system.
Asunto(s)
Kalanchoe , Miometrio , Oxitocina , Receptores de Oxitocina , Transducción de Señal , Vasopresinas , Humanos , Oxitocina/farmacología , Femenino , Kalanchoe/química , Receptores de Oxitocina/metabolismo , Miometrio/efectos de los fármacos , Miometrio/metabolismo , Transducción de Señal/efectos de los fármacos , Vasopresinas/farmacología , Vasopresinas/metabolismo , Extractos Vegetales/farmacología , Receptores de Vasopresinas/metabolismo , Receptores de Vasopresinas/genética , Vasotocina/farmacología , Vasotocina/análogos & derivados , Línea Celular , Pirrolidinas/farmacología , Calcio/metabolismo , IndolesRESUMEN
In the catfish Heteropneustes fossilis, three nonapeptide hormone genes were identified in the brain preoptic area (POA) and ovary: a pro-vasotocin (pro-vt) and two isotocin gene paralogs viz., a novel pro-ita and conventional pro-itb. In the present study, the regulatory role of catecholamines [CA: dopamine (DA), noradrenaline (NA), adrenaline (AD)] on the expression of these genes were investigated in vitro. DA (1, 10, and 100 ng/mL) inhibited significantly the mRNA expression in both the POA and ovary. NA upregulated the POA mRNA expression in a biphasic manner, the lower concentrations (1 ng and 10 ng) scaled up and the higher concentration (100 ng) scaled down the expression of pro-vt and pro-itb, while only the 1 ng NA scaled up the pro-ita expression. In the ovary, NA upregulated the mRNA expressions at all concentrations; the pro-vt expression was stimulated only at 10 and 100 ng. AD stimulated pro-vt and pro-ita expression in the POA at all concentrations but the pro-itb expression was inhibited at 1 and 10 ng, and stimulated at 100 ng concentrations. In the ovary, AD elicited varied effects; no significant change in pro-vt, a stimulation of pro-ita, and an inhibition of pro-itb at 1 ng, and stimulation of pro-itb at the 10 and 100 ng. The incubation of the POA and ovary with α-methylparatyrosine (MPT, 250 µg/mL, a tyrosine hydroxylase inhibitor) for 8 h downregulated the mRNA expression in the POA but unaltered the expression in the ovary. Pre-incubation with MPT for 4 h, followed by co-incubation with DA, NA or AD for 4 h elicited varied effects. In the POA, the co-incubations with the CAs rescued the inhibition due to MPT. The MPT + DA and MPT + AD treatments reduced the magnitude of the inhibition of pro-vt and pro-itb by MPT. But the pro-ita expression was modestly stimulated in the MPT + AD group. On the other hand, the MPT + NA treatment rescued the MPT effect and elicited 10-folds increase in the expression levels. In the ovary, the changes were: an inhibition in the MPT + DA group, no significant alteration in the MPT + NA group, and a mild stimulation in the MPT + AD group. The results suggest that CAs modulate brain and ovarian nonapeptide gene expression differentially, which is important in the neuroendocrine/endocrine integration of reproduction in the catfish.
Asunto(s)
Catecolaminas , Bagres , Animales , Femenino , Catecolaminas/farmacología , Catecolaminas/metabolismo , Ovario/metabolismo , Área Preóptica/metabolismo , Bagres/genética , Bagres/metabolismo , Norepinefrina/farmacología , Epinefrina/farmacología , Dopamina/metabolismo , Vasotocina/farmacología , Vasotocina/metabolismo , ARN Mensajero/metabolismoRESUMEN
The ability to respond to competition is critical for social behaviors involved in mating, territoriality and foraging. Physiological mechanisms of competitive social behaviors may determine not only baseline behavior, but possibly also the plasticity of the response to competition. We examined the effects of the neuropeptide arginine vasotocin (AVT), which is implicated in social behavior in non-mammalian vertebrates, on both spontaneous acoustic advertisement calling behavior and the plastic response to a simulated competitive challenge in Cope's gray treefrogs, Hyla chrysoscelis. We injected males either with AVT or a saline control and then analyzed recordings of spontaneous calling prior to playback, playback of average advertisement calls, playback of highly competitive advertisement calls, and spontaneous calling after playback. We found a tendency for AVT-treated males to be more likely to resume calling, and AVT males had higher call rates than control males, although they did not differ in pulse number or call effort. There were no differences between the AVT and control treatments in the plasticity of calling behavior in response to simulated competitors. Our results generally align with other studies on how AVT affects anuran vocalizations, and suggest that its primary effect is on motivation to call, with less of an effect on plasticity in response to competition. Nevertheless, these effects on call motivation are significant, because mating success is often determined more by participation in the chorus than by the values of specific call characteristics.
Asunto(s)
Vasotocina , Vocalización Animal , Animales , Anuros/fisiología , Masculino , Motivación , Reproducción , Vasotocina/farmacología , Vocalización Animal/fisiologíaRESUMEN
Oxytocin (OT) is a crucial regulator of reproductive behaviors, including parturition in mammals. Arg-vasopressin (AVP) is a nonapeptide homologous to Arg-vasotocin (AVT) in teleosts that has comparable affinity for the OT receptor. In the present study, ovoviviparous guppies (Poecilia reticulata) were used to study the effect of AVT on delivery mediated by the activation of prostaglandin (PG) biosynthesis via isotocin (IT) receptors (ITRs). One copy each of it and avt and two copies of itrs were identified in guppies. The results of the affinity assay showed that various concentrations of AVT and IT (10-6, 10-7, and 10-8 mol/L) significantly activated itr1 (P < 0.05). In vitro experiments revealed significant upregulation (P < 0.05) of cyclooxygenase 2 (cox2), which is the rate-limiting enzyme involved in PG biosynthesis, and itr1 by AVT and IT. Furthermore, dual in situ hybridization detected positive signals for itr1 and cox2 at the same site, implying that ITR1 may regulate cox2 gene expression. Measurement of prostaglandin F2a (PGF2a) concentrations showed that AVT induced PGF2a synthesis (P < 0.05) and that the effect of IT was not significant. Finally, intraperitoneal administration of PGF2a significantly induced premature parturition of guppies. This study is the first to identify and characterize AVT and ITRs in guppies. The findings suggest that AVT promotes PG biosynthesis via ITR and that PGF2a induces delivery behavior in ovoviviparous guppies.
Asunto(s)
Ciclooxigenasa 2/metabolismo , Receptores de Vasopresinas/metabolismo , Vasotocina/farmacología , Animales , Conducta Animal/efectos de los fármacos , Ciclooxigenasa 2/genética , Dinoprost/metabolismo , Dinoprost/farmacología , Oxitocina/análogos & derivados , Oxitocina/farmacología , Parto/efectos de los fármacos , Poecilia , Receptores de Vasopresinas/genética , Regulación hacia Arriba/efectos de los fármacosRESUMEN
Restraint stress (RS) is an unavoidable stress model that triggers activation of the autonomic nervous system, endocrine activity, and behavioral changes in rodents. Furthermore, RS induces secretion of oxytocin into the bloodstream, indicating a possible physiological role in the stress response in this model. The presence of oxytocin receptors in vessels and heart favors this possible idea. However, the role of oxytocin secreted in RS and effects on the cardiovascular system are still unclear. The aim of this study was to analyze the influence of oxytocin on cardiovascular effects during RS sessions. Rats were subjected to pharmacological (blockade of either oxytocin, vasopressin, or muscarinic receptors) or surgical (hypophysectomy or sinoaortic denervation) approaches to study the functional role of oxytocin and its receptor during RS. Plasma levels of oxytocin and vasopressin were measured after RS. RS increased arterial pressure, heart rate, and plasma oxytocin content, but not vasopressin. Treatment with atosiban (a Gi biased agonist) inhibited restraint-evoked tachycardia without affecting blood pressure. However, this effect was no longer observed after sinoaortic denervation, homatropine (M2 muscarinic antagonist) treatment or hypophysectomy, indicating that parasympathetic activation mediated by oxytocin secreted to the periphery is responsible for blocking the increase in tachycardic responses observed in the atosiban-treated group. Corroborating this, L-368,899 (oxytocin antagonist) treatment showed an opposite effect to atosiban, increasing tachycardic responses to restraint. Thus, this provides evidence that oxytocin secreted to the periphery attenuates tachycardic responses evoked by restraint via increased parasympathetic activity, promoting cardioprotection by reducing the stress-evoked heart rate increase.
Asunto(s)
Oxitocina/metabolismo , Restricción Física/fisiología , Estrés Psicológico/fisiopatología , Animales , Antagonistas de los Receptores de Hormonas Antidiuréticas/farmacología , Barorreflejo/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Presión Sanguínea/fisiología , Frecuencia Cardíaca/efectos de los fármacos , Frecuencia Cardíaca/fisiología , Masculino , Agonistas Muscarínicos/farmacología , Oxitocina/sangre , Parasimpatolíticos/farmacología , Ratas Wistar , Receptor Muscarínico M2/antagonistas & inhibidores , Receptores de Vasopresinas/fisiología , Estrés Psicológico/sangre , Taquicardia/fisiopatología , Tropanos/farmacología , Vasopresinas/sangre , Vasotocina/análogos & derivados , Vasotocina/farmacologíaRESUMEN
Arginine vasotocin (VT) is the basic neurohypophysial nonapeptide hormone in teleosts. VT is also distributed in the ovary of the catfish Heteropneustes fossilis and induces final oocyte maturation (FOM) and ovulation by stimulating the maturation-inducing hormone (MIH). The present study reports the effects of cAMP (0.5 mM), phosphodiesterase inhibitors (IBMX -0.5 mM and theophylline- 0.5 mM), the inositol triphosphate (IP3) receptor inhibitor heparin (10 µg/mL) and the Ca2+ chelator BAPTA-AM (25 µM) on VT (100 nM) - induced progestin stimulation, FOM and ovulation. Incubation of post-vitellogenic follicles with cAMP, IBMX and theophylline for 0, 8, 16 and 24 h stimulated basal secretion of progesterone (P4), 17-hydroxyprogesterone (17-P) and 17, 20ß-dihydroxy-4-pregnen-3-one (MIH) in a duration-dependent manner. The incubation of the follicles with heparin stimulated P4 modestly, and 17-P and MIH levels in a duration-dependent manner. The incubation of the follicles with BAPTA-AM stimulated P4 and MIH levels marginally and 17-P robustly. The stimulation was in the order cAMP > IBMX > theophylline > heparin > BAPTA-AM. The incubation of the follicles with VT stimulated P4, 17-P, MIH, GVBD and ovulation in a duration-dependent manner. The co-incubations with VT and the test compounds inhibited the VT-induced stimulation of P4, 17-P and MIH levels in a time-dependent manner in the order heparin > BAPTA-AM > cAMP > IBMX > theophylline. Concurrently, the VT-induced stimulation of GVBD and ovulation were also inhibited by the test compounds in the same order. The results show that VT induces FOM and ovulation preferentially acting through Ca2+ pathway and a crosstalk between Ca2+ and cAMP signaling pathways seems to integrate the processes.
Asunto(s)
Bagres , Vasotocina , Animales , Calcio , Femenino , Oocitos , Ovulación , Vasotocina/farmacologíaRESUMEN
Pharmacotherapies for the treatment of Benign Prostatic Hyperplasia (BPH) are targeted at reducing cellular proliferation (static component) or reducing smooth muscle tone (dynamic component), but response is unpredictable and many patients fail to respond. An impediment to identifying novel pharmacotherapies is the incomplete understanding of paracrine signalling. Oxytocin has been highlighted as a potential paracrine mediator of BPH. To better understand oxytocin signalling, we investigated the effects of exogenous oxytocin on both stromal cell proliferation, and inherent spontaneous prostate contractions using primary models derived from human prostate tissue. We show that the Oxytocin Receptor (OXTR) is widely expressed in the human prostate, and co-localises to contractile cells within the prostate stroma. Exogenous oxytocin did not modulate prostatic fibroblast proliferation, but did significantly (p < 0.05) upregulate the frequency of spontaneous contractions in prostate tissue, indicating a role in generating smooth muscle tone. Application of atosiban, an OXTR antagonist, significantly (p < 0.05) reduced spontaneous contractions. Individual tissue responsiveness to both exogenous oxytocin (R2 = 0.697, p < 0.01) and atosiban (R2 = 0.472, p < 0.05) was greater in tissue collected from older men. Overall, our data suggest that oxytocin is a key regulator of inherent spontaneous prostate contractions, and targeting of the OXTR and associated downstream signalling is an attractive prospect in the development of novel BPH pharmacotherapies.
Asunto(s)
Tono Muscular/efectos de los fármacos , Próstata/efectos de los fármacos , Hiperplasia Prostática/tratamiento farmacológico , Receptores de Oxitocina/genética , Vasotocina/análogos & derivados , Anciano , Proliferación Celular/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Contracción Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Músculo Liso/patología , Oxitocina/genética , Próstata/patología , Hiperplasia Prostática/patología , Receptores de Oxitocina/antagonistas & inhibidores , Vasotocina/administración & dosificación , Vasotocina/efectos adversos , Vasotocina/farmacologíaRESUMEN
Arginine vasotocin (AVT) and its homolog arginine vasopressin (AVP) modulate social behavior, including social communication. In anuran amphibians, male-male competition and female mate choice rely heavily on acoustic signaling. Behavioral experiments show that AVT influences motivation to call and vocal production. It may also influence how males process and respond to socially relevant auditory stimuli, but few studies have explored this possibility in this taxon. Túngara frogs produce a "whine" that is used for species recognition; in competition with other males they append one or more attractive "chucks" to the whine. Frequency modulation in the whine is an important cue for recognizing conspecifics, and gating of conspecific signals begins in the auditory midbrain. We used dynamic playback experiments to investigate the effects of exogenous AVT on males' responses to stimuli with species-typical and altered frequency modulation. We used avoidance of call overlap as evidence that a male recognizes a stimulus as salient and the production of attractive chucks as evidence of his competitive response to a proximate rival. We used call rate, whine duration, and whine frequency as measures of motivation and motor production. Males responded selectively to a stimulus with species-typical frequency modulation. Following treatment with AVT, they increased call rate and altered whines and chucks in a way that suggests increased air flow during the whine. We did not, however, find evidence that treatment with AVT alters the salience of frequency modulation in recognizing and responding to acoustic signals, at least for the stimuli used in this study.
Asunto(s)
Vasotocina , Vocalización Animal , Acústica , Animales , Anuros , Femenino , Masculino , Conducta Sexual Animal , Conducta Social , Vasotocina/farmacologíaRESUMEN
This ethopharmacological investigation comprised a long-term field study that examined the function of serotonergic and vasotonergic systems in territoriality. Adult territorial and non-territorial (silent) male coquí frogs (Eleutherodactylus coqui) were injected (IP) with either arginine vasotocin (AVT) or one of two serotonin agonists, 5-HT2A/2C selective agonist, (±) DOI - [(±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane], or 2) the 5-HT1A selective agonist, 8-OH-DPAT - [(±)-2-dipropylamino-8-hydroxy-1,2,3,4-tetrahydronaphthalene]. Control groups received saline injections. Each male received two injections. Following the first injection, whether AVT or a 5HT agonist, the male was observed so that behavior could be documented prior to the second injection, which consisted of the other drug class. All frogs were marked, placed back in the exact location as captured, and observed for all behaviors and vocalizations. Territoriality in E. coqui includes several behavioral components: movement into a calling site, presentation of dominant physical displays, emitting advertisement calls, and defense a territory (including the use of physical force and/or aggressive vocalizations). This investigation found that particular territorial behaviors were significantly influenced by 5HT and AVT action. Initiation of advertisement calling is activated by AVT and suppressed by 5HT, calling rate is affected by 5HT activation, presentation of dominant physical displays are activated by AVT and repressed by 5HT activation, and movement associated with activation of territorial behavior is stimulated by AVT. These data suggested that both 5HT and AVT have a profound impact on territoriality and are two fundamental neuroendocrine systems that govern territorial behavior in social systems.
Asunto(s)
Anuros/fisiología , Serotonina/fisiología , Territorialidad , Vocalización Animal/fisiología , 8-Hidroxi-2-(di-n-propilamino)tetralin/farmacología , Agresión/efectos de los fármacos , Animales , Masculino , Vasotocina/farmacología , Vocalización Animal/efectos de los fármacosRESUMEN
Estrogens play a key role in the sexual differentiation of the brain and behavior. While early estrogen actions exert masculinizing effects on the brain of male rodents, a diametrically opposite effect is observed in birds where estrogens demasculinize the brain of females. Yet, the two vertebrate classes express similar sex differences in the brain and behavior. Although ERα is thought to play a major role in these processes in rodents, the role of ERß is still controversial. In birds, the identity of the estrogen receptor(s) underlying the demasculinization of the female brain remains unclear. The aim of the present study was thus to determine in Japanese quail the effects of specific agonists of ERα (propylpyrazole triol, PPT) and ERß (diarylpropionitrile, DPN) administered at the beginning of the sensitive period (embryonic day 7, E7) on the sexual differentiation of male sexual behavior and on the density of vasotocin-immunoreactive (VT-ir) fibers, a known marker of the organizational action of estrogens on the quail brain. We demonstrate that estradiol benzoate and the ERß agonist (DPN) demasculinize male sexual behavior and decrease the density of VT-ir fibers in the medial preoptic nucleus and the bed nucleus of the stria terminalis, while PPT has no effect on these measures. These results clearly indicate that ERß, but not ERα, is involved in the estrogen-induced sexual differentiation of brain and sexual behavior in quail.
Asunto(s)
Encéfalo/anatomía & histología , Coturnix/fisiología , Receptor beta de Estrógeno/fisiología , Conducta Sexual Animal , Animales , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Coturnix/metabolismo , Estradiol/análogos & derivados , Estradiol/farmacología , Receptor alfa de Estrógeno/agonistas , Receptor alfa de Estrógeno/metabolismo , Receptor beta de Estrógeno/agonistas , Estrógenos/farmacología , Femenino , Masculino , Nitrilos/farmacología , Área Preóptica/efectos de los fármacos , Área Preóptica/metabolismo , Propionatos/farmacología , Caracteres Sexuales , Diferenciación Sexual/efectos de los fármacos , Conducta Sexual Animal/efectos de los fármacos , Vasotocina/farmacologíaRESUMEN
The reproductive process is usually controlled by the hypothalamic-pituitary-gonad axis in vertebrates, while Kiss/gonadotropin-releasing hormone (GnRH) system in the hypothalamus is required for mammalian reproduction but dispensable for fish reproduction. The regulation of follicle stimulating hormone/luteinizing hormone (LH) expression in fish species is still unknown. Here, we identified miR-200s on chromosome 23 (chr23-miR-200s) as important regulators for female zebrafish reproduction. Knockout of chr23-miR-200s (chr23-miR-200s-KO) resulted in dysregulated expression of luteinizing hormone beta lhb (luteinizing hormone beta) and some hormone genes in the pituitary as revealed by comparative transcriptome profiling, leading to failure of oocyte maturation and ovulation as well as defects in reproductive duct development. Chr23-miR-200s mainly expressed in the pituitary and regulated lhb expression by targeting the transcription repressor wt1a. Injection of human chorionic gonadotropin (hCG) could rescue the defects of oocyte maturation in chr23-miR-200s-KO zebrafish, whereas GnRH or LHRH-A2 could not, suggesting that Chr23-miR-200s regulated lhb expression in a GnRH-independent pathway. It was remarkable that either injection of carp pituitary extraction, or co-injection of hCG with synthetic oxytocin and vasotocin could greatly rescue the defects of both oocyte maturation and ovulation in chr23-miR-200s-KO zebrafish. Altogether, our findings highlight an important function of chr23-miR-200s in controlling oocyte maturation by regulation LH expression, and oxytocin and vasotocin are potentially responsible for the ovulation in fish species.
Asunto(s)
Cromosomas/genética , Regulación de la Expresión Génica/fisiología , MicroARNs/metabolismo , Proteínas de Pez Cebra/metabolismo , Animales , Gonadotropina Coriónica/farmacología , Femenino , Hormona Folículo Estimulante , Eliminación de Gen , Regulación de la Expresión Génica/efectos de los fármacos , Técnicas de Maduración In Vitro de los Oocitos , Hormona Luteinizante , Oocitos , Ovulación , Oxitocina/farmacología , Vasotocina/farmacología , Pez Cebra , Proteínas de Pez Cebra/genéticaRESUMEN
In reptiles, arginine vasotocin (AVT) impacts the performance of and response to visual social signals, but whether AVT also operates within the chemosensory system as arginine vasopressin (AVP) does in mammals is unknown, despite social odors being potent modifiers of competitive and appetitive behavior in reptiles. Here, we ask whether elevated levels of exogenous AVT impact rates of chemical display behavior (e.g. tongue flicks) in adult males, and whether conspecific males or females can chemically discriminate between competitor males based on differing levels of exogenous AVT in green anoles (Anolis carolinensis). We injected wild-caught green anole males with either AVT (AVT-Males) or a vehicle control (CON-Males) solution, then presented treated males with a conspecific stimulus (Intruder-Male or Intruder-Female) and filmed 30-minute interactions. We found that AVT-Males were faster than CON-Males to perform a tongue flick to conspecifics, and faster to chemically display toward Intruder-Females, suggesting AVT increased male interest in available chemical information during social encounters. Intruders performed more lip smack behavior when interacting with AVT-Males than with CON-Males, and Intruder-Males performed more tongue flick behavior when interacting with AVT-Males than with CON-Males, suggesting anoles can discriminate between conspecifics based on exogenous AVT levels. We also found a reduction in Intruder movement behavior when Intruders were paired with AVT-Males. This study provides empirical support for AVT-mediated chemosensory behavior in reptilian social interactions, in a microsmatic lizard species, suggesting the mechanism by which mammalian AVP and non-mammalian AVT mediate chemosensory behavior during social interactions may be evolutionarily conserved.
Asunto(s)
Lagartos/fisiología , Células Receptoras Sensoriales/efectos de los fármacos , Interacción Social/efectos de los fármacos , Vasotocina/farmacología , Animales , Conducta Animal/efectos de los fármacos , Células Quimiorreceptoras/efectos de los fármacos , Células Quimiorreceptoras/fisiología , Femenino , Locomoción/efectos de los fármacos , Masculino , Células Receptoras Sensoriales/fisiología , Conducta Sexual Animal/efectos de los fármacos , Conducta Sexual Animal/fisiología , Conducta Social , Territorialidad , Hábitos Linguales , Vasotocina/sangreRESUMEN
INTRODUCTION AND OBJECTIVES: Oxytocin (OT) has been widely linked to positive social interactions, and there is great interest in OT as a therapy for a variety of neuropsychiatric conditions. Recent evidence also suggests that OT can play an important role in the mediation of anxiety-associated defensive responses, including a role for serotonin (5-HT) neurotransmission in this action. However, it is presently unknown whether OT additionally regulates the expression of panic-related behaviors, such as escape, by acting in the dorsal periaqueductal gray (dPAG), a key panic-regulating area. This study aimed to investigate the consequence of OT injection in the dPAG on escape expression and whether facilitation of 5-HT neurotransmission in this midbrain area is implicated in this action. METHODS: Male Wistar rats were injected with OT in the dPAG and tested for escape expression in the elevated T-maze (ETM) and dPAG electrical stimulation tests. Using the latter test, OT's effect was also investigated after previous intra-dPAG injection of the OT receptor antagonist atosiban, the preferential antagonists of 5-HT1A and 5-HT2A receptors, WAY-100635 and ketanserin, respectively, or systemic pretreatment with the 5-HT synthesis inhibitor p-CPA. RESULTS: OT impaired escape expression in the two tests used, suggesting a panicolytic-like effect. In the ETM, the peptide also facilitated inhibitory avoidance acquisition, indicating an anxiogenic effect. Previous administration of atosiban, WAY-100635, ketanserin, or p-CPA counteracted OT's anti-escape effect. CONCLUSIONS: OT and 5-HT in the dPAG interact in the regulation of panic- and anxiety-related defensive responses. These findings open new perspectives for the development of novel therapeutic strategies for the treatment of anxiety disorders.
Asunto(s)
Ansiolíticos/farmacología , Oxitocina/farmacología , Pánico/efectos de los fármacos , Sustancia Gris Periacueductal/efectos de los fármacos , Serotonina/fisiología , Animales , Conducta Animal/efectos de los fármacos , Estimulación Eléctrica , Electrodos Implantados , Reacción de Fuga/efectos de los fármacos , Masculino , Ratas , Ratas Wistar , Receptor de Serotonina 5-HT1A/efectos de los fármacos , Receptor de Serotonina 5-HT2A/efectos de los fármacos , Receptores de Oxitocina/antagonistas & inhibidores , Antagonistas de la Serotonina/farmacología , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología , Vasotocina/análogos & derivados , Vasotocina/farmacologíaRESUMEN
BACKGROUND: The herbal medicine Bryophyllum pinnatum has been used as a tocolytic agent in anthroposophic medicine and, recently, in conventional settings alone or as an add-on medication with tocolytic agents such as atosiban or nifedipine. We wanted to compare the inhibitory effect of atosiban and nifedipine on human myometrial contractility in vitro in the absence and in the presence of B. pinnatum press juice (BPJ). METHODS: Myometrium biopsies were collected during elective Caesarean sections. Myometrial strips were placed under tension into an organ bath and allowed to contract spontaneously. Test substances alone and at concentrations known to moderately affect contractility in this setup, or in combination, were added to the organ bath, and contractility was recorded throughout the experiments. Changes in the strength (measured as area under the curve (AUC) and amplitude) and frequency of contractions after the addition of all test substances were determined. Cell viability assays were performed with the human myometrium hTERT-C3 and PHM1-41 cell lines. RESULTS: BPJ (2.5 µg/mL), atosiban (0.27 µg/mL), and nifedipine (3 ng/mL), moderately reduced the strength of spontaneous myometrium contractions. When BPJ was added together with atosiban or nifedipine, inhibition of contraction strength was significantly higher than with the tocolytics alone (p = 0.03 and p < 0.001, respectively). In the case of AUC, BPJ plus atosiban promoted a decrease to 48.8 ± 6.3% of initial, whereas BPJ and atosiban alone lowered it to 70.9 ± 4.7% and to 80.9 ± 4.1% of initial, respectively. Also in the case of AUC, BPJ plus nifedipine promoted a decrease to 39.9 ± 4.6% of initial, at the same time that BPJ and nifedipine alone lowered it to 78.9 ± 3.8% and 71.0 ± 3.4% of initial. Amplitude data supported those AUC data. The inhibitory effects of BPJ plus atosiban and of BPJ plus nifedipine on contractions strength were concentration-dependent. None of the test substances, alone or in combination, decreased myometrial cell viability. CONCLUSIONS: BPJ enhances the inhibitory effect of atosiban and nifedipine on the strength of myometrial contractions, without affecting myometrium tissue or cell viability. The combination treatment of BPJ with atosiban or nifedipine has therapeutic potential.
Asunto(s)
Kalanchoe/química , Miometrio/efectos de los fármacos , Nifedipino/antagonistas & inhibidores , Extractos Vegetales/farmacología , Nacimiento Prematuro/prevención & control , Tocolíticos/antagonistas & inhibidores , Contracción Uterina/efectos de los fármacos , Vasotocina/análogos & derivados , Adulto , Antagonismo de Drogas , Femenino , Humanos , Técnicas In Vitro , Miometrio/fisiopatología , Nifedipino/farmacología , Embarazo , Tocolíticos/farmacología , Vasotocina/antagonistas & inhibidores , Vasotocina/farmacología , Adulto JovenRESUMEN
RESEARCH QUESTION: What is the in-vitro effect of oxytocin receptor (OTR) antagonism on parameters of receptivity in human endometrial explants and endometrial stromal cell lines cultured in oestradiol-rich conditions mimicking ovarian stimulation? DESIGN: Experimental in-vitro study on endometrial tissue explants collected by aspiration biopsy from 30 women undergoing fertility treatment and cultured endometrial tHESC cell line. The study examined the effects of high oestradiol, oxytocin and OTR antagonist on parameters of decidualization (cell viability and prolactin secretion) as well as cyclooxygenase-1/2 (COX-1/2) activity and prostaglandin F2α (PGF2α) secretion. Changes in expression of OXTR and COX-2 genes were examined using quantitative polymerase chain reaction (qPCR). RESULTS: In experiments on cultured endometrial cell line, high oestradiol and oxytocin similarly limited the viability of cells. In cultured endometrial explants both also decreased the secretion of prolactin (a marker of decidualization) and augmented endometrial COX-2 activity and formation of PGF2α. Oxytocin antagonist atosiban was confirmed to reverse the above effects, both in the endometrial line and endometrial explants. Addition of atosiban to cultures acted analogously in experiments employing both oxytocin and high oestradiol. CONCLUSIONS: Oxytocin antagonist reversed the effects of high oestradiol and oxytocin on parameters related to endometrial receptivity in conditions mimicking ovarian stimulation. This might point to a novel, endometrium-related mechanism to support embryo implantation achieved by the application of oxytocin antagonist prior to embryo transfer.